Results 161 to 170 of about 27,791 (179)

Metabolism, Disposition, Excretion, and Potential Transporter Inhibition of 7-16, an Improving 5-HT_2A Receptor Antagonist and Inverse Agonist for Parkinson's Disease. [PDF]

Molecules
Hu Z, Wang W, Yang H, Zhao F, Sha C, Mi W, Yin S, Wang H, Tian J, Ye L.   +9 more
europepmc   +1 more source

5-HT1A receptor, 5-HT2A receptor and serotonin transporter binding in the human auditory cortex in depression [PDF]

J Psychiatry Neurosci, 2019
Steinberg LJ, Underwood MD, Bakalian MJ, Kassir SA, Mann JJ, Arango V.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Peter Schellongowski   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh, Sagar Lonial
exaly  

Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity

Nature, 2022
Anat Levit, Jeffrey F Diberto, Ramona Rodriguiz   +2 more
exaly  

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor

Cell, 2020
Kuglae Kim, Tao Che, Ouliana Panova
exaly  

Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia

Lancet, The, 1997
Julie Williams, Peter McGuffin
exaly  

5-HT2A receptor polymorphism and steady state receptor expression in schizophrenia

Lancet, The, 1997
Brian Dean
exaly  

5-HT2A promoter polymorphism −1438G/A, anorexia nervosa, and obsessive-compulsive disorder

Lancet, The, 1998
Benjamin D Greenberg, David Goldman
exaly